Literature DB >> 6312189

Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation.

S W Barthold, A L Smith.   

Abstract

Three-week-old outbred mice were inoculated intranasally with a mildly pathogenic strain of mouse hepatitis virus (MHV-S). Tissues were analyzed for distribution of infectious virus, lesions, and viral antigen at intervals up to 49 days after inoculation. Sera were tested for neutralizing antibody to MHV-S. Within the first week of infection, virus was isolated from lung and brain of most mice and liver of one mouse, but not from blood, spleen, or intestine. Microscopic lesions consisted of mild olfactory mucosal necrosis, neuronal necrosis of olfactory bulbs and tracts, lymphoplasmacytic infiltrates and vacuolation in the brain, mild nonsuppurative pulmonary perivascular lymphocyte infiltration, focal interstitial pneumonia, and focal necrotizing hepatitis. The presence and distribution of MHV antigen, as determined by indirect immunofluorescence, correlated with virus recovery and acute lesions. No virus or antigen was demonstrable beyond day 7. Serum antibody was first detected on day 10, and titers peaked on day 28 after infection.

Entities:  

Mesh:

Year:  1983        PMID: 6312189

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  19 in total

1.  Monoclonal antibody solution hybridization assay for detection of mouse hepatitis virus infection.

Authors:  D B Casebolt; C B Stephensen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Virus strain specificity of challenge immunity to coronavirus.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Olfactory neural pathway in mouse hepatitis virus nasoencephalitis.

Authors:  S W Barthold
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Passively acquired challenge immunity to enterotropic coronavirus in mice.

Authors:  F R Homberger; S W Barthold
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Maternally-derived passive immunity to enterotropic mouse hepatitis virus.

Authors:  F R Homberger
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Comparison of Track XI fluorometric immunoassay with Bio-EnzaBead enzyme-linked immunosorbent assay for detection of serum antibody to mouse hepatitis virus.

Authors:  M C La Regina; J Lonigro; L Woods; W C Hall; R E Doyle
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

9.  Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.

Authors:  A L Smith; S W Barthold; D S Beck
Journal:  Antiviral Res       Date:  1987-12       Impact factor: 5.970

Review 10.  Infectious diseases of the upper respiratory tract: implications for toxicology studies.

Authors:  J I Everitt; C B Richter
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.